In an effort to speed up progress on its genetic testing portfolio and its planned therapeutic work, Interleukin Genetics Inc. acquired consumer products firm Alan James Group LLC and secured $30 million in financing. (BioWorld Today)

In an effort to speed up progress on its genetic testing portfolio and its planned therapeutic work, Interleukin Genetics Inc. acquired consumer products firm Alan James Group LLC and secured $30 million in financing. (BioWorld Today)